Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Laurent Pharmaceuticals Welcomes New Investors And Announces Scientific Breakthrough With Lau-7b In Cystic Fibrosis
LPNEWS

Laurent Pharmaceuticals Welcomes New Investors And Announces Scientific Breakthrough With Lau-7b In Cystic Fibrosis

by prnewswire.com posted 8months ago 171 views
MONTREAL, Oct. 25, 2018 /PRNewswire/ - Laurent Pharmaceuticals Inc., a biopharmaceutical company developing LAU-7b (oral fenretinide) first-in-class pro-resolving drug for Cystic Fibrosis (CF), today announced new financing led by Keiretsu Forum Mid-Atlantic, Anges Quebec and Anges Quebec ...

In this article